ArticleScientific reports2025
Diagnostic value of neutrophil to lymphocyte ratio and serum biomarkers in chronic osteomyelitis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Osteomyelitis: Epidemiology, Classification, Pathophysiology, Clinical Features, Diagnosis, and Management.MedComm · 2026Review
- Discriminating Osteoarticular Infection Bacterial Aetiology Using Immune-Inflammatory Biomarkers.Microorganisms · 2026Article
- An Evaluation of Novel Inflammatory Biomarkers in Children withPathogens (Basel, Switzerland) · 2026Article
- Review
- MRI-based radiomics explainable model for predicting recurrence of limb chronic osteomyelitis in limb bones treated by Masquelet technique.Bone & joint research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Chronic osteomyelitis (COM) is a persistent bone infection associated with severe complications, making early and accurate diagnosis essential. Traditional diagnostic methods, including imaging and bacterial cultures, are often limited by low sensitivity, long processing times, and the inability to detect infections in certain clinical scenarios. In this study, we evaluated the diagnostic utility of inflammatory biomarkers for COM, including neutrophil to lymphocyte ratio (NLR), C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6). A total of 200 participants, including 100 COM patients and 100 healthy controls, were enrolled. Our results showed that Gram-positive bacteria were more prevalent (59%), with Staphylococcus aureus being the most frequently isolated pathogen. Antibiotic resistance profiling revealed that Gram-positive bacteria exhibited high resistance to Penicillins but remained sensitive to Vancomycin and Linezolid. In contrast, Gram-negative bacteria showed high resistance to certain Penicillins, while sensitive to Carbapenems. Inflammatory marker levels (NLR, CRP, TNF-α, and IL-6) were significantly elevated in COM patients, with higher levels in Gram-negative infections. Multivariate logistic regression analysis and ROC curve analysis demonstrated that these inflammatory markers were significant predictors of COM, and the combination of these biomarkers showed superior diagnostic performance. Our findings suggest that NLR, CRP, TNF-α, and IL-6 are valuable diagnostic biomarkers for COM, and their combination enhances diagnostic precision, offering a promising tool for clinical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.